Drug Information Association Logo

In-company Training

Preserve Your Travel Budget
and Maximize Your Time


DIA is recognized throughout the life sciences community as the definitive source for knowledge and content. That’s why top companies around the world trust DIA to deliver current, relevant, and effective education and professional In-company Training.

Join some of the most successful companies who chose DIA In-company Training to support their training goals and objectives:

• Abbott Laboratories  • Merck
• Actelion  • Millennium: Takeda Oncology Co.
• AMAG Pharmaceuticals  • Novartis 
• Amgen  • Novo Nordisk
• Auxilium Pharmaceuticals, Inc.  • Organogenesis Inc.
• Eli Lilly and Company  • Sepracor
• Fresenius Biotech  • Shire Human Genetic Therapies 
• Genentech  • Takeda Pharmaceuticals
• Janssen Alzheimer Immunotherapy R&D  • UNC Chapel Hill
• Lernia Training Solutions  • Vertex Pharmaceuticals
• Medtronic, Inc.   

We know you and your team are busy professionals with full schedules and limited budgets. DIA can tailor a training course or curriculum specifically for your team, department, or entire company.  You will receive quality content and expert delivery - right in your workplace, created for you and your company, all while earning continuing education credits. Contact DIA now to bring our outstanding training program to your company!

Please select from the rows below to display course details.

In-Company Training 

Title
Adaptive Design 3474872
Advanced Clinical Statistics for Nonstatisticians 10386
Advanced Signal Detection - Tools, Triage, Evaluation, and Escalation 3443006
Art of Writing a Clinical Overview 24458
Clinical Project Management 13242
Clinical Statistics for Non-Statisticians 10381
CRO - Clinical Vendor Oversight: Vendor Life Cycle Management for Quality and Performance 2124278
Developing Standard Operating Procedures 10380
Development of a Clinical Study Report 10379
Electronic Submissions: The Next Era of Electronic Submissions 2526234
Enterprise Resource Management 16489
Essentials of European Regulatory Affairs 10377
Essentials of Project Management 10308
Executing and Controlling Biopharmaceutical Projects 11335
Fundamentals of Clinical Research Monitoring 10376
Fundamentals of Project Management for the Nonproject Manager 10309
Global Considerations for Regulatory Strategy Development 30108
Good Clinical Practices for the Clinical Research Professional 10375
High Performance Biopharm Teams 14215
How to Prepare for a Safety Inspection 20691
Introduction to Computer Systems Validation 19537
Introduction to Portfolio Management and Performance Metrics 16188
Introduction to Signal Detection and Data Mining 20694
Medical Approach in Diagnosis and Management of ADRs 11120
Navigating Chemistry, Manufacturing and Controls through the Drug Development Process 19367
New Drug Product Development and Life Cycle Management 13461
Oversight of Clinical Monitoring: Trends and Strategies 13871
Overview of Drug Development 10310
Overview of Drug Development in Japan 12679
Postmarketing Drug Safety and Pharmacovigilance 21684
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum 29675
Premarketing Clinical Safety and Pharmacovigilance 21656
Preparing for a US FDA Advisory Committee Meeting 28296
Project Information, Communication, and Knowledge Management 16153
Project Risk Management 16145
Proven Strategies for Creating an Effective Clinical Research Program 28775
Regulatory Affairs for Biologics 21649
Regulatory Affairs Part I: The IND Phase 10307
Regulatory Affairs Part II: The NDA Phase 10306
Regulatory Affairs: The IND, NDA, and Postmarketing 10305
Risk Management and Safety Communication Strategies 22320
Strategies for Good Clinical Practice Audits 10374
The Basics of Clinical Data Management From Start to End 10382